Patents Assigned to UCL Business PLC
  • Publication number: 20120064290
    Abstract: An article comprising: a substrate; and over at least part of a surface of said substrate an outer coating of hydroxyapatite and an intermediate bonding layer bonded to said substrate and to said outer coating, wherein a mechanical interlock is present between said substrate and said outer coating.
    Type: Application
    Filed: November 30, 2009
    Publication date: March 15, 2012
    Applicants: THE FURLONG RESEARCH CHARITABLE FOUNDATION, UCL BUSINESS PLC
    Inventors: Minoo Esat, William Bonfield, Mohan Edirisinghe, Jie Huang, Xiang Li
  • Publication number: 20120019316
    Abstract: An apparatus for driving a resonant circuit is disclosed.
    Type: Application
    Filed: January 20, 2010
    Publication date: January 26, 2012
    Applicant: UCL BUSINESS PLC
    Inventors: Simon Richard Hattersley, Paul Southern, Quentin Andrew Pankhurst, Mathew Kallumadil
  • Publication number: 20110308968
    Abstract: A method for dispersing nanomaterial comprising an electrochemical process, a solution of dispersed nanomaterial, comprising individual charged nanomaterial at a concentration of about O.1 mgm?1 or more and a solvent and an electrochemical cell are described.
    Type: Application
    Filed: July 3, 2009
    Publication date: December 22, 2011
    Applicant: UCL Business PLC
    Inventors: Christopher Howard, Neal Skipper, Milo Shaffer, Sian Fogden
  • Publication number: 20110287258
    Abstract: A method for dispersing nanotubes, comprising contacting the nanotubes with an electronic liquid comprising a metal and an amine solvent, a solution of dispersed nanotuhes, comprising individual nanotuhes at a concentration of greater than about 0.01 mgml?1 and a solvent and a nanotube crystal comprising a close packed array of nanotubes, wherein the crystal has a thickness of 100 nm or more are described.
    Type: Application
    Filed: July 3, 2009
    Publication date: November 24, 2011
    Applicants: IMPERIAL INNOVATIONS LTD., UCL BUSINESS PLC
    Inventors: Christopher Howard, Skipper Neal, Milo Shaffer, Sian Fogden
  • Patent number: 8063104
    Abstract: Compounds of formula (I) have been found to be useful as inhibitors of DDAH.
    Type: Grant
    Filed: November 11, 2005
    Date of Patent: November 22, 2011
    Assignee: UCL Business PLC
    Inventors: Patrick John Thompson Vallance, James Mitchell Leiper, David Lawrence Selwood, Sharon Rossiter, Basil Hartzoulakis
  • Publication number: 20110236464
    Abstract: The invention relates to a membrane for supporting cells, especially RPE cells. The membrane is useful in the treatment of conditions such as age related macular degeneration.
    Type: Application
    Filed: April 8, 2009
    Publication date: September 29, 2011
    Applicant: UCL BUSINESS PLC
    Inventors: Peter Coffey, Lyndon Da Cruz, Karen Cheetham
  • Publication number: 20110206264
    Abstract: Among other things, a method is disclosed comprising: receiving image data representing an image; processing the data to generate orientation information; processing the data using the orientation information to measure a quantity called local phase in a direction perpendicular to the orientation of a putative vessel; using the phase measurements from three collinear image locations or from two locations to detect the centerline of a symmetric image structure, such as a blood vessel, and to locate a center-point defined by the intersection of the centerline with the line created by the measurement locations.
    Type: Application
    Filed: January 21, 2011
    Publication date: August 25, 2011
    Applicant: UCL Business PLC
    Inventors: Jeffrey Ng Sing Kwong, Alistair Richard Fielder, Clare Margaret Wilson
  • Publication number: 20110178379
    Abstract: A method of aiding in the diagnosis or prediction of degenerative joint disease in a joint of a patient. The method comprises obtaining a test spectrum of Raman scattered radiation from cartilage tissue in the joint, and analysing the test spectrum, or one or more regions thereof, to assess whether the test spectrum is consistent with the patient having, or subsequently developing, degenerative joint disease in the joint.
    Type: Application
    Filed: May 13, 2009
    Publication date: July 21, 2011
    Applicant: UCL Business PLC
    Inventors: Jayesh Dudhia, Paul Francis McMillan, Edward Richard Cornell Draper, Steven Firth
  • Publication number: 20110091217
    Abstract: A method and apparatus for transporting three or more radio signals of the same frequency, such as multiple input multiple output (MIMO) radio signals, over optical fiber on a single optical carrier using a phase quadrature double sideband frequency translation technique is disclosed.
    Type: Application
    Filed: February 18, 2009
    Publication date: April 21, 2011
    Applicant: UCL BUSINESS PLC
    Inventors: Chin-Pang Liu, Alwyn John Seeds
  • Patent number: 7869567
    Abstract: Phase contrast imaging is achieved using a sample mask 8 and a detector mask (6). X-rays emitted from x-ray source (2) are formed into individual beams (16) by sample mask which pass through sample (14) and arrive at individual pixels (12) of the detector (4) through detector mask (6). The individual x-ray beams are arranged to hit the pixel edge (20) of individual rows of pixels, individual columns of pixels or individual pixels. Small deviations ? in the individual beams (16) cause a significant increase or decrease in the signal hitting the exposed area (22) of the pixel resulting in a significant phase contrast signal.
    Type: Grant
    Filed: September 3, 2007
    Date of Patent: January 11, 2011
    Assignee: UCL Business PLC
    Inventors: Alessandro Olivo, Robert D. Speller
  • Publication number: 20110002912
    Abstract: The present invention relates to a composition for improving stem cell integration. The present invention also relates to a method of improving stem cell integration and kits for improving stem cell integration.
    Type: Application
    Filed: December 5, 2008
    Publication date: January 6, 2011
    Applicants: UCL BUSINESS PLC, CAMBRIDGE ENTERPRISE LIMITED
    Inventors: Gloria A. Limb, James Fawcett, Jean Lawrence, Peng T. Khaw
  • Patent number: 7851782
    Abstract: An example photodetector includes a waveguide structure having an active waveguide comprising an absorber for converting photons conveying an optical signal into charge carriers conveying a corresponding electrical signal; a carrier collection layer for transporting the charge carriers conveying the electrical signal; and a secondary waveguide immediately adjacent to the carrier collection layer, for receiving the photons to be detected, and which is evanescently coupled to the active waveguide.
    Type: Grant
    Filed: March 30, 2007
    Date of Patent: December 14, 2010
    Assignee: UCL Business PLC
    Inventors: Alwyn John Seeds, Cyril Renaud, Michael Robertson
  • Publication number: 20100297018
    Abstract: A method for assessing prognosis in an individual suffering from liver failure, which method comprises detecting endotoxin in the individual, for example by determining the neutrophil function in the individual. The method can be used to determine whether there is an increased risk of infection in the individual, an increased risk of organ failure in the individual, an increased risk of mortality in the individual and/or an increased risk that the individual will not respond positively to treatment with an immunosuppressive agent, a steroid or an antibiotic.
    Type: Application
    Filed: October 29, 2007
    Publication date: November 25, 2010
    Applicant: UCL Business PLC
    Inventors: Rajiv Jalan, Rajeshwar P. Mookerjee, Vanessa Stadlbauer, Nathan Davies
  • Publication number: 20100284922
    Abstract: The invention relates to the use of a cell death marker labelled with a wavelength-optimised label for identifying cell death in the eye. Suitable cell death markers are the Annexins and fragments and derivatives thereof. The invention also relates to a pharmaceutical composition comprising a cell death marker labelled with a wavelength-optimised label and a method for monitoring cell death in the eye using a cell death marker labelled with a wavelength-optimised label.
    Type: Application
    Filed: December 15, 2008
    Publication date: November 11, 2010
    Applicant: UCL Business plc
    Inventors: Francesca Cordeiro, Stephen Moss, Frederick Fitzke
  • Publication number: 20100278896
    Abstract: A solid, implantable dosage form comprising a therapeutically active agent in solid form, optionally with one or more pharmaceutically acceptable excipients, wherein the one or more excipients, when present, do not lead to a significant delay or prolongation of the release of active agent, as compared to an equivalent dosage form containing no excipients when tested in vitro.
    Type: Application
    Filed: November 17, 2008
    Publication date: November 4, 2010
    Applicant: UCL BUSINESS PLC
    Inventors: Peng T. Khaw, Stephen Brocchini
  • Publication number: 20100278747
    Abstract: The invention relates to a carrier for delivering agents to the posterior region of the eye, the carrier comprising a Vitamin E derivative, especially tocopherol. The carrier may also comprise a cell death marker, such as an annexin.
    Type: Application
    Filed: December 19, 2008
    Publication date: November 4, 2010
    Applicant: UCL BUSINESS PLC
    Inventors: Francesca Cordeiro, Stephen Moss
  • Publication number: 20100249925
    Abstract: A method of surface treatment of at least part of a surface of an implant, said method comprising: electrochemical deposition of a layer containing calcium and phosphorus ions onto a metallic substrate; and incorporation of a therapeutic agent into said electrochemically deposited layer and an implant so treated.
    Type: Application
    Filed: February 8, 2008
    Publication date: September 30, 2010
    Applicant: UCL BUSINESS PLC
    Inventors: Gordon Blunn, Yaser Ghani, Paul Unwin
  • Publication number: 20100223258
    Abstract: An algorithm is provided which uses a model-based concept of a cluster and scores items using a score representative of the probability that a given item has been generated from the same distribution as one or more query items. The items are represented by a feature vector xi comprising a plurality of digitally represented features xij the method including: receiving an input identifying the query items; for each of the other items computing a score which is a function of a conditional probability of the feature vectors xij of the query items being generated from the generating distribution formula (I) given that the respective other item is generated from the generating distribution formula (I) and returning a score for each of the other items, a list of some or all of the other items, sorted by their respective score, or a list of n other items which have the highest score.
    Type: Application
    Filed: December 1, 2006
    Publication date: September 2, 2010
    Applicant: UCL BUSINESS PLC
    Inventors: Zoubin Ghahramani, Katherine Anne Heller
  • Publication number: 20100168067
    Abstract: This invention relates to the finding that the presence of polymorphisms in and around the farnesyl diphosphate synthase (FDPS) gene is predictive of the densitometric response of patients with bone disorders, such as osteoporosis, subsequent to commencing treatment with amino-bisphosphonates. Methods relating to the identification of individuals having bone disorders which are responsive to bisphosphonates and predicting the responsiveness of individuals with bone disorders to treatment with a bisphosphonate are provided.
    Type: Application
    Filed: March 19, 2007
    Publication date: July 1, 2010
    Applicant: UCL BUSINESS PLC
    Inventors: John Chamberlain, Halina Fitz-Clarence, Mark Thomas
  • Publication number: 20100069607
    Abstract: A glycopeptide of the formula S-L-X—P, wherein: S is selected from an optionally protected monosaccharide, an optionally protected polysaccharide, a polyalkylene oxide chain and a group of the formula II, wherein R1 and R3 are independently selected from H or Ac, R4 is Ac, and R2 is a group of formula IV, wherein R7 and R8 are each independently selected from an optionally protected monosaccharide and an optionally protected polysaccharide, A, B, C and D are each independently 1 or 2, and m is 1 to 5; -L- is a moiety of the formula III wherein R5 and R6 are independently selected from H and Me and n is 1 to 3; and P is a peptide chain containing at least one amino acid having on its side chain the atom X, wherein X is an oxygen, a sulphur atom or a —CH2— moiety.
    Type: Application
    Filed: June 29, 2007
    Publication date: March 18, 2010
    Applicant: UCL BUSINESS PLC
    Inventors: Derek MacMillan, Javier Blanc